AKT1S1 and neoplasm: Independent analyses of tumour samples by immuno-histochemistry and Western blot confirmed significant suppression of AKT and PRAS40 phosphorylation by AZD8186 (both markers of PI3K pathway activation) in 786-0 and U87-MG tumour xenografts that lack functional PTEN.